Eligibility Multiple Sclerosis NCT00262314

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
platelet count >100,000 cells/µl
Description

platelet count

Data type

boolean

Alias
UMLS CUI [1]
C0032181
granulocyte count > 2000 cells/µl
Description

granulocyte count

Data type

boolean

Alias
UMLS CUI [1]
C0857490
age 18-65 years
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
negative pregnancy test for female patients who are biologically capable of becoming pregnant, even if they are taking birth control
Description

pregnancy test

Data type

boolean

Alias
UMLS CUI [1]
C0032976
for patients of reproductive age, agreement to practice effective contraception throughout the study and for 6 months following the last administration of novantrone®
Description

contraception

Data type

boolean

Alias
UMLS CUI [1]
C0700589
signed inform consent.
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of cardiac risk factors:
Description

cardiac risk factors

Data type

boolean

Alias
UMLS CUI [1]
C2024776
history of congestive heart failure
Description

congestive heart failure

Data type

boolean

Alias
UMLS CUI [1]
C0018802
lvef < 50% determined by echocardiography or muga
Description

lvef

Data type

boolean

Alias
UMLS CUI [1]
C0428772
previous treatment with novantrone®, other anthracenediones, or anthracyclines
Description

anthracenediones, anthracyclines

Data type

boolean

Alias
UMLS CUI [1]
C0003174
UMLS CUI [2]
C0282564
prior mediastinal radiotherapy or total lymphoidal irradiation
Description

radiotherapy

Data type

boolean

Alias
UMLS CUI [1]
C1522449
ast, alt, bilirubin > 2x upper limits of normal
Description

bilirubin, ast, alt

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
severe untreated infection (including current urinary tract infection)
Description

infection

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205082
nursing or pregnant women)
Description

pregnant or nursing

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147

Similar models

Eligibility Multiple Sclerosis NCT00262314

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
platelet count
Item
platelet count >100,000 cells/µl
boolean
C0032181 (UMLS CUI [1])
granulocyte count
Item
granulocyte count > 2000 cells/µl
boolean
C0857490 (UMLS CUI [1])
age
Item
age 18-65 years
boolean
C0001779 (UMLS CUI [1])
pregnancy test
Item
negative pregnancy test for female patients who are biologically capable of becoming pregnant, even if they are taking birth control
boolean
C0032976 (UMLS CUI [1])
contraception
Item
for patients of reproductive age, agreement to practice effective contraception throughout the study and for 6 months following the last administration of novantrone®
boolean
C0700589 (UMLS CUI [1])
informed consent
Item
signed inform consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
cardiac risk factors
Item
presence of cardiac risk factors:
boolean
C2024776 (UMLS CUI [1])
congestive heart failure
Item
history of congestive heart failure
boolean
C0018802 (UMLS CUI [1])
lvef
Item
lvef < 50% determined by echocardiography or muga
boolean
C0428772 (UMLS CUI [1])
anthracenediones, anthracyclines
Item
previous treatment with novantrone®, other anthracenediones, or anthracyclines
boolean
C0003174 (UMLS CUI [1])
C0282564 (UMLS CUI [2])
radiotherapy
Item
prior mediastinal radiotherapy or total lymphoidal irradiation
boolean
C1522449 (UMLS CUI [1])
bilirubin, ast, alt
Item
ast, alt, bilirubin > 2x upper limits of normal
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
infection
Item
severe untreated infection (including current urinary tract infection)
boolean
C0009450 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
pregnant or nursing
Item
nursing or pregnant women)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])